Institute for Cell Biology, University of Bonn, Ulrich-Haberland-Str. 61A, 53121 Bonn, Germany.
Biochemical Institute, University of Kiel Medical School, Olshausenstr. 40, 24098 Kiel, Germany.
J Cell Sci. 2023 May 1;136(9). doi: 10.1242/jcs.260806. Epub 2023 May 12.
Several ATP- and cytosol-dependent fusion processes between membranes of the endocytic and exocytic pathways have been biochemically reconstituted. Here, we present a phagosome-lysosome fusion reaction that is driven by micromolar concentrations of Ca2+ in the absence of ATP and cytosol. Investigating classical fusion and Ca2+-driven fusion (CaFu) side-by-side in vitro, using the same membrane preparations, we show that CaFu is faster than standard fusion (StaFu), leads to larger fusion products and is not blocked by established inhibitors of StaFu. A Ca2+ concentration of ∼120 µM supports maximal membrane attachment, and 15 µM Ca2+ supports maximal membrane fusion, indicating that Ca2+ has both a membrane-binding activity and a fusion-promoting activity. StaFu and CaFu are inhibited by a mutant form of α-SNAP (NAPA) that does not support soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) activation, and both are inhibited by a mixture of the cytosolic domains of three cognate Q-SNARE proteins, demonstrating a role of SNAREs in Ca2+-driven membrane merger. CaFu is independent of the Ca2+-regulated proteins synaptotagmin-7, calmodulin, and annexins A2 and A7. We propose that CaFu corresponds to the last step of phagosome-lysosome fusion, when a raised Ca2+ concentration from the compartment lumen activates SNAREs for fusion.
几种内吞和外排途径的膜之间的 ATP 和细胞质依赖融合过程已在生化上重建。在这里,我们提出了一种吞噬体-溶酶体融合反应,该反应在没有 ATP 和细胞质的情况下,由微摩尔浓度的 Ca2+ 驱动。通过使用相同的膜制剂,在体外对经典融合和 Ca2+ 驱动的融合(CaFu)进行并排研究,我们表明 CaFu 比标准融合(StaFu)更快,导致更大的融合产物,并且不受 StaFu 的既定抑制剂的阻断。约 120 μM 的 Ca2+ 浓度支持最大的膜附着,而 15 μM 的 Ca2+ 浓度支持最大的膜融合,表明 Ca2+ 既有膜结合活性又有融合促进活性。StaFu 和 CaFu 被不支持可溶性 N-乙基马来酰亚胺敏感因子附着蛋白受体(SNARE)激活的 α-SNAP(NAPA)的突变形式抑制,并且两者都被三种同源 Q-SNARE 蛋白的细胞质结构域的混合物抑制,表明 SNARE 在 Ca2+ 驱动的膜融合中起作用。CaFu 不依赖于 Ca2+ 调节蛋白突触融合蛋白-7、钙调蛋白和膜联蛋白 A2 和 A7。我们提出,CaFu 对应于吞噬体-溶酶体融合的最后一步,当腔内的 Ca2+ 浓度升高时,激活 SNARE 以进行融合。